Rapt Therapeutics Inc share price logo

Rapt Therapeutics Inc Share Price

NASDAQ: RAPT

Small Cap

$17.35

+1.13

(+6.97%)

as on

Rapt Therapeutics Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $15.94
    $17.66
    downward going graph

    8.13%

    Downside

    1.79%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.67
    $26.56
    downward going graph

    67.35%

    Downside

    53.08%

    Upside

    downward going graph

Rapt Therapeutics Inc share price movements today

Previous Close
$16.22
Open
$15.94
Volume
232.7K
Day's Low - High
$15.94 - $17.66
52 Week Low - High
$5.67 - $26.56

Rapt Therapeutics Inc Historical Returns

1 Month Return
+ 38.16 %
3 Month Return
+ 94.95 %
1 Year Return
+ 3.97 %
3 Year Return
-92.36 %
5 Year Return
-94.43 %

Rapt Therapeutics Inc Stock Fundamentals & Key Indicators

Check Rapt Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$268.2M

EPS (TTM)

-1.9599

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-112.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

14735600.00%

Rapt Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Rapt Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$268.2M-94.43%NA0.00%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Rapt Therapeutics Inc Stock including INR - Dollar returns

The Rapt Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Rapt Therapeutics Inc investment value today

Current value as on today

₹1,16,203

Returns

₹16,203

(+16.2%)

Returns from Rapt Therapeutics Inc Stock

₹11,218 (+11.22%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Rapt Therapeutics Inc Stock

Based on 17 analysts

BUY

64.71%

Buy

35.29%

Hold

0.00%

Sell

Based on 17 analysts, 64.71% of analysts recommend a 'BUY' rating for Rapt Therapeutics Inc. Average target price of $23.6

Rapt Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Rapt Therapeutics Inc.

What analysts predicted

26.48%UPSIDE

Target Price

$23.6

Current Price

$17.35

Analyzed by

17 Analysts

Target

$23.60

Rapt Therapeutics Inc target price $23.6, a slight upside of 26.48% compared to current price of $17.35. According to 17 analysts rating.

Rapt Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Rapt Therapeutics Inc Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-38% versus previous 30 day period

Rapt Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
5
-
-
-
-
-
-
Gross Profit
0
0
0
4
0
0
-
-
-
0
Operating Income
-31
-28
-33
-33
-32
-29
-19
-54
-19
-19
EBITDA
-31
-28
-33
-32
-32
-29
-19
-54
-19
-17
Interest Expense
2
-
-
2
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-29
-25
-31
-30
-30
-27
-18
-53
-17
-17
Income Tax Expense
-2
0
0
2
0
-
-
-
-
-
Net Income
-26
-25
-31
-30
-30
-27
-18
-53
-17
-17
Net Profit Margin
0.00%
0.00%
0.00%
-583.89%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Rapt Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
0
5
3
1
-
-
Gross Profit
-1
-1
-1
5
3
1
-3
-
Operating Income
-29
-36
-43
-53
-69
-85
-127
-136
EBITDA
-27
-35
-42
-52
-68
-84
-125
-126
Interest Expense
-
-
2
2
0
1
-
-
Depreciation
1
1
1
1
0
1
1
1
Income Before Tax
-29
-36
-42
-51
-69
-83
-116
-129
Income Tax Expense
-
0
0
0
0
-1
-
-
Net Income
-29
-36
-42
-52
-68
-81
-116
-129
Net Profit Margin
0.00%
0.00%
-4598.61%
-1049.03%
-1788.83%
-5362.21%
0.00%
0.00%

Rapt Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-25
-31
-30
-30
-27
-18
-53
-17
-17
Operating Cash Flow
-28
-21
-27
-27
-28
-17
-10
-52
-11
Investing Cash Flow
32
25
20
15
19
18
0
-57
-7
Financing Cash Flow
0
0
0
9
0
-
143
-
0
Change in Cash
4
3
-6
-2
-8
0
131
-109
-18

Rapt Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-36
-42
-52
-69
-83
-116
-129
Operating Cash Flow
-32
-35
-40
-61
-70
-97
-83
Investing Cash Flow
-3
0
-87
-81
-45
104
52
Financing Cash Flow
52
49
75
141
131
1
152
Change in Cash
16
13
-52
0
14
8
122

Global Institutional Holdings in Rapt Therapeutics Inc

Funds
Holdings
Medicxi Ventures Management (Jersey) Ltd
16.9%
Orbimed Advisors, LLC
9.93%
TCG Crossover Management, LLC
9.9%
Foresite Capital Management VI LLC
9.45%
RTW INVESTMENTS, LLC
8.89%

Insights on Rapt Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, RAPT stock has moved up by 28.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 207.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 54.8%

About Rapt Therapeutics Inc

rapt therapeutics is a clinical stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. utilizing its proprietary discovery and development engine, the company is developing highly selective small molecules designed to modulate the critical immune drivers underlying these diseases. rapt has discovered and advanced two unique drug candidates, flx475 and rpt193, each targeting c-c motif chemokine receptor 4 (ccr4), for the treatment of cancer and inflammation, respectively. the company is also pursuing a range of targets that are in the discovery stage of development.
OrganisationRapt Therapeutics Inc
Headquarters561 Eccles Avenue, South San Francisco, CA, United States, 94080
IndustryHealth Technology
CEODr. Brian Russell Wong M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Rapt Therapeutics Inc

Name

Title

Mr. Rodney K. B. Young

CFO, Principal Accounting Officer & Secretary

Dr. William Ho M.D., Ph.D.

Chief Medical Officer

Steve Young Ph.D.

Vice President of Technology

Dr. Paul Kassner Ph.D.

Senior Vice President of Biology

Dr. Nipun Davar MBA, Ph.D.

Senior Vice President of Technical Operations

Dr. Brian Russell Wong M.D., Ph.D.

CEO, President & Director

Dr. Dirk G. Brockstedt Ph.D.

Chief Scientific Officer

Mr. Michael Listgarten

General Counsel

Ms. Gwen R. Carscadden

Chief Human Resources Officer

Ms. Jennifer Nicholson

Senior Vice President of Regulatory Affairs & Quality Assurance

FAQs

What is Rapt Therapeutics Inc share price today?

Rapt Therapeutics Inc share price today is $17.35 as on at the close of the market. Rapt Therapeutics Inc share today touched a day high of $17.66 and a low of $15.94.

What is the 52 week high and 52 week low for Rapt Therapeutics Inc share?

Rapt Therapeutics Inc share touched a 52 week high of $26.56 on and a 52 week low of $5.67 on . Rapt Therapeutics Inc stock price today i.e. is closed at $17.35,which is 34.68% down from its 52 week high and 206.26% up from its 52 week low.

What is Rapt Therapeutics Inc's market capitalisation today?

Rapt Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Rapt Therapeutics Inc Stock (RAPT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Rapt Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rapt Therapeutics Inc Shares that will get you 0.0865 shares as per Rapt Therapeutics Inc share price of $17.35 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Rapt Therapeutics Inc Stock (RAPT) from India?

Indian investors can start investing in Rapt Therapeutics Inc (RAPT) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Rapt Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Rapt Therapeutics Inc share’s latest price of $17.35 as on September 16, 2025 at 1:29 am IST, you will get 0.5764 shares of Rapt Therapeutics Inc. Learn more about fractional shares .

What are the returns that Rapt Therapeutics Inc has given to Indian investors in the last 5 years?

Rapt Therapeutics Inc stock has given -94.43% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?